Our top pick for
Building a portfolio
Ekso Bionics Holdings, Inc is a medical instruments & supplies business based in the US. Ekso Bionics shares (EKSO) are listed on the NASDAQ and all prices are listed in US Dollars. Ekso Bionics employs 67 staff and has a trailing 12-month revenue of around USD$10.3 million.
|Latest market close||USD$9.2|
|52-week range||USD$2.25 - USD$9.34|
|50-day moving average||USD$5.3079|
|200-day moving average||USD$5.4039|
|Wall St. target price||USD$10|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.319|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-15)||12.47%|
|1 month (2020-12-23)||32.37%|
|3 months (2020-10-23)||93.28%|
|6 months (2020-07-23)||28.13%|
|1 year (2020-01-23)||2,359.89%|
|2 years (2019-01-23)||457.58%|
|3 years (2018-01-23)||493.55%|
|5 years (2016-01-22)||945.45%|
|Revenue TTM||USD$10.3 million|
|Gross profit TTM||USD$6.8 million|
|Return on assets TTM||-36.26%|
|Return on equity TTM||-196.6%|
|Market capitalisation||USD$58 million|
TTM: trailing 12 months
There are currently 175,456 Ekso Bionics shares held short by investors – that's known as Ekso Bionics's "short interest". This figure is 7.1% up from 163,844 last month.
There are a few different ways that this level of interest in shorting Ekso Bionics shares can be evaluated.
Ekso Bionics's "short interest ratio" (SIR) is the quantity of Ekso Bionics shares currently shorted divided by the average quantity of Ekso Bionics shares traded daily (recently around 108306.17283951). Ekso Bionics's SIR currently stands at 1.62. In other words for every 100,000 Ekso Bionics shares traded daily on the market, roughly 1620 shares are currently held short.
However Ekso Bionics's short interest can also be evaluated against the total number of Ekso Bionics shares, or, against the total number of tradable Ekso Bionics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ekso Bionics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Ekso Bionics shares in existence, roughly 20 shares are currently held short) or 0.0195% of the tradable shares (for every 100,000 tradable Ekso Bionics shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ekso Bionics.
Find out more about how you can short Ekso Bionics stock.
We're not expecting Ekso Bionics to pay a dividend over the next 12 months.
Ekso Bionics's shares were split on a 1:15 basis on 25 March 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ekso Bionics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Ekso Bionics shares which in turn could have impacted Ekso Bionics's share price.
Over the last 12 months, Ekso Bionics's shares have ranged in value from as little as $2.25 up to $9.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ekso Bionics's is 2.3349. This would suggest that Ekso Bionics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. It primarily offers EksoNR, a bionic suit that provides the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke; and EksoUE, a wearable assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms, as well as reduce fatigue while rehabilitation sessions to achieve a larger active range of motion. The company's Ekso devices are primarily used in a hospital and rehabilitation setting. It has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.